Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study shows metabolic, cardiovascular consequences of untreated sleep apnea

Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects.

31 Aug 2017

Gout patient hospitalizations: what’s causing the increase?

We looked at all hospitalizations in patients with gout. The concern is that gout is often considered as a disease of just the joints, specifically of the big toe. Yet, there have been quite a lot of studies that have talked about the many other comorbidities that occur because of hyperuricemia and gout. The idea is that it's not just the crystal deposits in the joint, but other consequences that are happening because of this disease in the rest of the body.

31 Aug 2017

'Open gym' format reduces cardiac rehabilitation wait times, study reports

Changing from scheduled appointments to an "open gym" format can reduce waiting times for cardiac rehabilitation, reports a study in the September/October issue of Journal of Cardiopulmonary Rehabilitation and Prevention.

30 Aug 2017

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Scientists may have found a clue to why people living with HIV have double the likelihood of developing heart disease.

30 Aug 2017

Nutrition scientists investigate impact of dietary fats on metabolically healthy obese adults

Metabolically healthy obese adults consuming a diet high in unsaturated fat and low in saturated fat may be able to decrease their total cholesterol by 10 points, a new study suggests.

30 Aug 2017

Moderate intake of carbohydrate and fat associated with better health, says global study

An international study suggests that a diet consisting of a moderate consumption of fat, fruits and vegetables, coupled with avoidance of high levels of carbohydrates, is linked with a decreased risk of death.

30 Aug 2017

Study reports link between fruit, vegetable, legume consumption and CVD risk, mortality

A large dietary study from 18 countries, across 7 geographic regions has found that even relatively moderate intake of fruit, vegetables and legumes such as beans and lentils may lower a person's risk of cardiovascular disease (CVD) and death.

29 Aug 2017

Low-dose hormone therapy may be effective in easing sleep issues for recently menopausal women

For many women, the side effects of menopause don't call it a day when they do. Between 40 and 60 percent of women in perimenopause and early menopause face issues with sleep because of this physical change. The majority also report hot flashes and night sweats, which can be disruptive to falling and staying asleep.

29 Aug 2017

Slow walkers could be at higher risk of heart disease, say researchers

A team of researchers at the NIHR Leicester Biomedical Research Centre, UK - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has concluded that middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population.

29 Aug 2017

Study links psoriasis severity to increased risk of death

The more the surface area of the body is covered by psoriasis, the greater the risk of death for the patient suffering from the condition, according to a new analysis by researchers in the Perelman School of Medicine at the University of Pennsylvania.

29 Aug 2017

Moderate intake of nutrients found to be best for health

Research with more than 135,000 people across five continents has shown that a diet which includes a moderate intake of fat and fruits and vegetables, and avoidance of high carbohydrates, is associated with lower risk of death.

29 Aug 2017

First-in-class investigational drug lowers LDL cholesterol for up to one year, study finds

Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.

29 Aug 2017

Clinical benefit of LDL cholesterol lowering therapies could depend on reduction in apoB particles

The benefit of lowering low-density lipoprotein (LDL) cholesterol depends on how it is lowered, according to late-breaking results from a naturally randomised genetic trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in JAMA.

29 Aug 2017

LSU Health New Orleans to receive $735,000 for improving heart attack recovery

LSU Health New Orleans will receive $735,000 over two years to study the effectiveness of the first patented drug-eluting guidewire in preventing a complication that can occur following treatment of heart attacks with angioplasty.

28 Aug 2017

Reducing inflammation without lowering cholesterol significantly lowers rate of recurrent cardiovascular events

The researchers from Brigham and Women's Hospital this week have come up with a new study which shows that reducing the inflammation among patients who have already had a heart attack before could prevent the risk of getting more cardiovascular events. The study is published in the latest issue of the New England Journal of Medicine.

28 Aug 2017

NSAIDs may not be safe for arthritis patients with cardiovascular risk, study shows

Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, according to late-breaking results from the PRECISION-ABPM study presented today in a Hot Line Session at ESC Congress and published in EHJ.

28 Aug 2017

Anti-inflammatory therapy reduces incidence of lung cancer

In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique opportunity: to explore the effectiveness of giving a drug to patients before cancer emerges.

28 Aug 2017

Drug reduces inflammation to lower cardiovascular disease and lung cancer risk

The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line - LBT Session at ESC Congress1 and published in the NEJM.

28 Aug 2017

Drug combination improves outcomes in patients with stable coronary or peripheral artery disease

Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in the NEJM.

28 Aug 2017

Drug combination superior in preventing further heart complications in people with vascular disease

A major international study has found that the combination of two drugs - rivaroxaban and aspirin -- is superior to aspirin alone in preventing further heart complications in people with vascular disease.

28 Aug 2017

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study shows metabolic, cardiovascular consequences of untreated sleep apnea

Gout patient hospitalizations: what’s causing the increase?

'Open gym' format reduces cardiac rehabilitation wait times, study reports

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Nutrition scientists investigate impact of dietary fats on metabolically healthy obese adults

Moderate intake of carbohydrate and fat associated with better health, says global study

Study reports link between fruit, vegetable, legume consumption and CVD risk, mortality

Low-dose hormone therapy may be effective in easing sleep issues for recently menopausal women

Slow walkers could be at higher risk of heart disease, say researchers

Study links psoriasis severity to increased risk of death

Moderate intake of nutrients found to be best for health

First-in-class investigational drug lowers LDL cholesterol for up to one year, study finds

Clinical benefit of LDL cholesterol lowering therapies could depend on reduction in apoB particles

LSU Health New Orleans to receive $735,000 for improving heart attack recovery

Reducing inflammation without lowering cholesterol significantly lowers rate of recurrent cardiovascular events

NSAIDs may not be safe for arthritis patients with cardiovascular risk, study shows

Anti-inflammatory therapy reduces incidence of lung cancer

Drug reduces inflammation to lower cardiovascular disease and lung cancer risk

Drug combination improves outcomes in patients with stable coronary or peripheral artery disease

Drug combination superior in preventing further heart complications in people with vascular disease

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in